Good morning :)
Place Order
Add to Watchlist

Nectar Lifesciences Ltd

NECLIFE Share Price

13.710.59% (+0.08)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹266 cr, stock is ranked 2,303

High Risk

Stock is 5.72x as volatile as Nifty

NECLIFE Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

Avg

Can be considered moderately valued vs the market

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹266 cr, stock is ranked 2,303

High Risk

Stock is 5.72x as volatile as Nifty

NECLIFE Performance & Key Metrics

NECLIFE Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-0.750.28—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.405.620.61%

NECLIFE Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

NECLIFE Company Profile

Nectar Lifesciences Limited is a pharmaceutical company. The Company's operations include manufacturing and marketing of oral and sterile cephalosporin's, phytochemicals and allied products.

NECLIFE Similar Stocks (Peers)

Compare with peers Compare with peers 

NECLIFE Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
37.38
37.38
1Y Return
2.86%
2.86%
Buy Reco %
94.44
94.44
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
70.41
70.41
1Y Return
27.67%
27.67%
Buy Reco %
76.92
76.92
Cipla Ltd
CIPLA
PE Ratio
20.43
20.43
1Y Return
7.20%
7.20%
Buy Reco %
58.06
58.06
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
18.33
18.33
1Y Return
1.41%
1.41%
Buy Reco %
51.61
51.61
Lupin Ltd
LUPIN
PE Ratio
30.89
30.89
1Y Return
1.53%
1.53%
Buy Reco %
72.22
72.22
Compare with Peers

NECLIFE Forecast

NECLIFE Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

NECLIFE

NECLIFE

Income

Balance Sheet

Cash Flow

NECLIFE Income Statement

NECLIFE Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of -6.71%, vs industry avg of 10.04%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.94% to 0.4%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue1,666.371,882.292,788.912,370.701,547.081,680.151,566.851,698.661,674.96525.88
Raw Materialssubtract1,145.851,417.322,268.131,862.831,052.821,207.321,200.841,242.451,250.72885.38
Power & Fuel Costsubtract75.4491.85103.4792.7284.63101.41127.39129.52104.16
Employee Costsubtract75.5474.6576.5478.1970.5971.9175.1481.7193.61
Selling & Administrative Expensessubtract59.9852.2367.9967.0172.0466.8662.6461.3971.17
Operating & Other expensessubtract62.484.062.5645.89179.4962.794.6617.46179.87
Depreciation/Amortizationsubtract62.2564.3163.2660.7760.2556.9759.1260.7262.3916.47
Interest & Other Itemssubtract117.41115.20148.14125.83112.0478.8179.4987.1474.5847.89
Taxes & Other Itemssubtract12.0810.4111.225.68-11.509.03-18.2413.28-47.85-68.81
EPS2.472.332.121.42-3.271.12-1.080.22-5.07-15.83
DPS0.050.050.050.050.000.000.000.000.000.00
Payout ratio0.020.020.020.040.000.000.000.000.000.00
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

NECLIFE Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025FY 2025

Annual report

PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
 

NECLIFE Stock Peers

NECLIFE Past Performance & Peer Comparison

NECLIFE Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Nectar Lifesciences Ltd-2.340.28—
Sun Pharmaceutical Industries Ltd37.385.640.94%
Torrent Pharmaceuticals Ltd70.4117.730.80%
Cipla Ltd20.433.441.20%

NECLIFE Stock Price Comparison

Compare NECLIFE with any stock or ETF
Compare NECLIFE with any stock or ETF
NECLIFE
Loading...

NECLIFE Holdings

NECLIFE Shareholdings

NECLIFE Promoter Holdings Trend

NECLIFE Promoter Holdings Trend

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

NECLIFE Institutional Holdings Trend

NECLIFE Institutional Holdings Trend

No institutional holdings trend are available

Tickertape Separator

NECLIFE Shareholding Pattern

NECLIFE Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding51.84%0.00%3.54%0.58%44.03%

Jun 2025

Sep 2025

Dec 2025

Jan 2026

NECLIFE Shareholding History

NECLIFE Shareholding History

Dec '24MarJunSepDec '25Jan0.73%1.65%0.81%0.62%0.52%0.58%

Mutual Funds Invested in NECLIFE

Mutual Funds Invested in NECLIFE

No mutual funds holding trends are available

Top 1 Mutual Funds holding Nectar Lifesciences Ltd

Funds (Top 1)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Bandhan BSE Healthcare Index Fund Direct Plan-Growth

Growth
0.0012%0.02%0.00%118/123 (+1)

Compare 3-month MF holding change on Screener

NECLIFE Insider Trades & Bulk Stock Deals

NECLIFE Insider Trades & Bulk Stock Deals

Loading...

smallcases containing NECLIFE stock

smallcases containing NECLIFE stock

Looks like this stock is not in any smallcase yet.

NECLIFE Events

NECLIFE Events

NECLIFE Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

NECLIFE has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

NECLIFE Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

NECLIFE has not given any dividends in last 5 years

NECLIFE Upcoming Dividends

NECLIFE Upcoming Dividends

No upcoming dividends are available

NECLIFE Past Dividends

NECLIFE Past Dividends

Cash Dividend

Ex DateEx DateSep 11, 2020

Final
Final | Div/Share: ₹0.05

Dividend/Share

₹0.05

Ex DateEx Date

Sep 11, 2020

Cash Dividend

Ex DateEx DateSep 19, 2019

Final
Final | Div/Share: ₹0.05

Dividend/Share

₹0.05

Ex DateEx Date

Sep 19, 2019

Cash Dividend

Ex DateEx DateSep 19, 2018

Final
Final | Div/Share: ₹0.05

Dividend/Share

₹0.05

Ex DateEx Date

Sep 19, 2018

Cash Dividend

Ex DateEx DateSep 20, 2017

Final
Final | Div/Share: ₹0.05

Dividend/Share

₹0.05

Ex DateEx Date

Sep 20, 2017

Cash Dividend

Ex DateEx DateSep 22, 2016

Final
Final | Div/Share: ₹0.10

Dividend/Share

₹0.10

Ex DateEx Date

Sep 22, 2016

NECLIFE Stock News & Opinions

NECLIFE Stock News & Opinions

Earnings
Nectar Lifescience consolidated net profit rises 82.02% in the December 2025 quarter

Net profit of Nectar Lifescience rose 82.02% to Rs 14.27 crore in the quarter ended December 2025 as against Rs 7.84 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Nectar Lifescience announces board meeting date

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 23 January 2026.Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
Nectar Lifescience to conduct board meeting

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 3 December 2025.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Nectar Lifescience reports consolidated net loss of Rs 176.01 crore in the September 2025 quarter

Net loss of Nectar Lifescience reported to Rs 176.01 crore in the quarter ended September 2025 as against net profit of Rs 5.60 crore during the previous quarter ended September 2024. Sales declined 12.74% to Rs 5.00 crore in the quarter ended September 2025 as against Rs 5.73 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales5.005.73 -13 OPM %-6.60-10.30 - PBDT-0.300.10 PL PBT-0.50-0.35 -43 NP-176.015.60 PL Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Nectar Lifescience announces board meeting date

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Nectar Lifescience to convene AGM

Nectar Lifescience announced that the 30th Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Nectar Lifescience reports consolidated net loss of Rs 63.23 crore in the June 2025 quarter

Net loss of Nectar Lifescience reported to Rs 63.23 crore in the quarter ended June 2025 as against net profit of Rs 2.97 crore during the previous quarter ended June 2024. Sales declined 21.79% to Rs 280.67 crore in the quarter ended June 2025 as against Rs 358.85 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales280.67358.85 -22 OPM %-22.0511.09 - PBDT-80.2420.38 PL PBT-96.754.92 PL NP-63.232.97 PL Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Nectar Lifescience reports standalone net loss of Rs 63.23 crore in the June 2025 quarter

Net loss of Nectar Lifescience reported to Rs 63.23 crore in the quarter ended June 2025 as against net profit of Rs 2.97 crore during the previous quarter ended June 2024. Sales declined 21.79% to Rs 280.67 crore in the quarter ended June 2025 as against Rs 358.85 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales280.67358.85 -22 OPM %-22.0511.09 - PBDT-80.2320.38 PL PBT-96.754.92 PL NP-63.232.97 PL Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Nectar Lifescience schedules board meeting

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 14 August 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Nectar Lifescience to hold board meeting

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 23 July 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Nectar Lifesciences Ltd (NECLIFE) today?

    The share price of NECLIFE as on 5th February 2026 is ₹13.71. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Nectar Lifesciences Ltd (NECLIFE) share?

    The past returns of Nectar Lifesciences Ltd (NECLIFE) share are
    • Past 1 week: -1.15%
    • Past 1 month: -30.41%
    • Past 3 months: -2.14%
    • Past 6 months: -7.18%
    • Past 1 year: -62.87%
    • Past 3 years: -29.33%
    • Past 5 years: -33.93%

  3. What are the peers or stocks similar to Nectar Lifesciences Ltd (NECLIFE)?

    The peers or stocks similar to Nectar Lifesciences Ltd (NECLIFE) include:

  4. What is the market cap of Nectar Lifesciences Ltd (NECLIFE) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Nectar Lifesciences Ltd (NECLIFE) is ₹266.33 Cr as of 5th February 2026.

  5. What is the 52 week high and low of Nectar Lifesciences Ltd (NECLIFE) share?

    The 52-week high of Nectar Lifesciences Ltd (NECLIFE) is ₹38.90 and the 52-week low is ₹13.05.

  6. What is the PE and PB ratio of Nectar Lifesciences Ltd (NECLIFE) stock?

    The P/E (price-to-earnings) ratio of Nectar Lifesciences Ltd (NECLIFE) is -2.34. The P/B (price-to-book) ratio is 0.28.

  7. Which sector does Nectar Lifesciences Ltd (NECLIFE) belong to?

    Nectar Lifesciences Ltd (NECLIFE) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Nectar Lifesciences Ltd (NECLIFE) shares?

    You can directly buy Nectar Lifesciences Ltd (NECLIFE) shares on Tickertape. Simply sign up, connect your demat account and place your order.